FTSE 100 gains amid positive broker ratings

The FTSE 100 ticked higher on Friday as traders continued to move into UK stocks after this week’s budget.

The measures announced on Wednesday were much better than some had first feared. Investors will be encouraged by the lack of immediate impact on consumer spending, and the absence of immediate impact on the economy will be negligible.

The longer-term picture is much harder to gauge, but reaction from business hasn’t been overly negative, with JPMorgan even pledging to build a brand new 12,000-person headquarters in Canary Wharf.

This mild confidence was reflected in UK equities, with the FTSE 100 edging higher.

“The FTSE 100 looks set to end the week in decent fashion and US futures point to post-Thanksgiving gains when Wall Street opens for business,” says AJ Bell head of markets Dan Coatsworth.

“UK housebuilders remain in decent fettle after the Budget – which didn’t contain any nasty surprises in terms of property taxes, bar the so-called ‘mansion tax’.

“The exception to the sector’s positivity is Berkeley which has greater exposure to the premium end of the market where the new supplementary council tax charges are more relevant.”

Berkeley Group Holdings shares slipped 0.7% while Persimmon added 0.1%. Rightmove was also marginally higher, with the housing market left largely unscathed by the budget.

Whitbread was the top faller after being hit by two broker downgrades. 

“Broker ratings changes don’t always grab investors’ attention but a double downgrade from analysts on Premier Inn owner Whitbread has sparked a big reaction,” Coatsworth said.

“The share price has been shaken to its foundations by Bernstein making a handbrake turn from a positive to a negative view on the hotels group.”

Whitbread shares were down 4.5% at the time of writing. 

Weir Group was the top riser, adding 1.9%, after Exane BNP reinitiated the stock with an outperform rating.

UK MedTech, Occuity, Opens Investment Round to Deliver Unique Non-Invasive Disease Screening

In an era where early detection can transform outcomes, one British MedTech company is turning the world’s attention to a surprising but powerful diagnostic tool – the human eye.

Occuity is a Reading-based innovator pioneering the emerging field of Oculomics, the study of how the eye can reveal insights into wider systemic health. Using light to scan through the eye and analyse the reflections returned, Occuity’s patented optical technology can detect subtle biomarkers linked not only to eye conditions such as glaucoma and myopia, but also to major systemic diseases including diabetes and Alzheimer’s.

As CEO and Co-Founder, Dr. Dan Daly highlights: “Ultimately, our aim is to replace invasive finger stick tests used by millions daily to measure glucose, with a simple, pain free scan of the eye”

Revolutionising diagnostics through light

Whilst a non-invasive glucose meter is the main goal, the company is taking a strategic approach to delivering it. At the heart of the Occuity’s work is a versatile optical platform technology that enables a pipeline of handheld, non-contact devices capable of delivering clinical-grade measurements quickly and painlessly. Its first commercial product built on the platform, the PM1 Pachymeter, provides precise corneal thickness measurements used in  glaucoma screening and laser eye surgery, whilst its next device, the AX1 Axiometer, is aimed at the fast-growing myopia management market – targeting a disease forecast to affect half the world’s population by 2050.

Further along the roadmap are devices designed to identify and monitor key biomarkers for diabetes and Alzheimer’s, where non-invasive screening could provide an invaluable step forward in early detection and patient management. This includes the future development of the ‘Indigo’ – a non-invasive glucose meter, which aims to measure glucose levels through the eye.

Platform power and protection

Occuity’s core advantage lies in its patented optical technology platform, which serves as the foundation for multiple devices. The company currently holds 15 patent families (14 granted, one pending) with a further six in draft. Each new product builds upon the same core architecture – from optics and scanning systems to alignment and data algorithms – creating scalability and strong intellectual-property protection.

As CTO and Co-founder Dr Robin Taylor explains, “Occuity is a patent-heavy organisation by design. Our patents are structured into a robust patent thicket that safeguards not just our core optical platform, but every product that stems from it, giving us real strength and long-term value as we grow.”

Accessibility meets opportunity

Traditional optical instruments are often large, complex and costly. Occuity’s design philosophy flips this on its head, focusing on portability, simplicity and patient comfort. Its devices require no chin rest, dark room or consumables, making them cost-effective for clinicians and easy to deploy not only in hospitals but in point of care providers such as optometry practices, community settings, pharmacies and even in the home.

This approach does not just simplify healthcare delivery; it broadens access to advanced diagnostics. With more than 19 global distributors already on board, Occuity is well placed to bring its technology to scale.

Investing in the future of health

With global markets for diabetes care (projected at US $62.73 billion by 2032) and Alzheimer’s diagnostics growing rapidly (US $14.14 billion by 2032), Occuity’s platform offers investors exposure to several multi-billion-pound opportunities, all built around a proven core technology.

The company’s crowdfunding round on Republic Europe gives investors the chance to join its mission from as little as £30. For those looking for an ethical, high-growth investment in an area with vast potential impact, Occuity stands out as one to watch.

“We’re using the eye as a window into the health of the body,” says CEO and Co-founder Dan Daly. “Our goal is to make disease detection and monitoring smarter, faster and completely non-invasive, improving lives on a global scale. Significantly, from an investor perspective, whilst our work on our non-invasive glucose meter is really exciting, we’re not a one trick pony and our technology is being proven by our current products.”

As Oculomics moves from research into real-world applications, Occuity’s optical platform places it firmly at the forefront of this healthcare revolution.

Occuity’s Republic Europe crowdfunding campaign is now live, giving you the opportunity to back a company that has proven its technology, established early revenues and built a clear roadmap to scale.

Disclosure: This article is for information purposes only and does not constitute investment advice. Capital is at risk.

AIM movers: Founder’s offer for essensys and European Metals Holdings gets grant for Cinovec

2

European Metals Holdings (LON: EMH) joint venture Geomet has secured a €360m grant for the Cinovec lithium and tin project in the Czech Republic.  This is Europe’s most advanced lithium project. EMH owns 49% of Geomet, which is expected to publish a definitive feasibility study soon. Zeus has modelled a 25-year mine life and an NPV10 of $1.04bn. Zeus has a fair value share price of 75p. The share price jumped 56% to 19.5p.

Boohoo (LON: DEBS) shares continue to rebound following yesterday’s results showing a fall in pre-tax loss. Goldman Sachs has raised its share price target for the online retailer from 16p to 17p, but still says sell, while Barclays has cut its target from 13p to 11p and remains underweight. Despite, the share share price has improved a futher 22.7% to 22.45p. The new incentive package for chief executive Dan Finley could be worth £148.1m if the share price reaches 300p within five years.  

Shares in TV and film vehicle and equipment hie company Facilities by ADF (LON: ADF) recovered following yesterday’s trading statement. Second half revenues improved, but not as much as hoped, and the full year pre-tax forecast has been downgraded from £2.1m to £1.3m. Net debt could be £13.5m by the year end. Next year, higher utilisation levels would mean that pre-tax profit could improve to £1.6m. The share price recovered 14.5% to 17.75p.

Logistics Development Group (LON: LDG) has published an unchanged NAV of 26.7p/share at the end of September 2025. The share price rose 6.27% to 15.25p.

FALLERS

Tern (LON: TERN) says it has insufficient cash to meet investment calls from the Sure Valley Ventures Enterprise Capital Fund. Tern agreed to invest up to £5m and so far, has invested £1.3m. Tern will be a defaulting investor and could forfeit its investment or have it transferred to another investor. Alternatively, the investment may be retained, but some rights to distributions could be lost. Tern has enough cash for its own requirements until early in 2026. The share price slumped 22.2% to 0.35p.

An AGM update by Quadrise (LON: QED) reveals that negotiations on trial agreements for the company’s enhanced fuel with Cargill and MSC are continuing. MSC is concerned about ongoing supply after the trial. Valdor has secured funding for a pilot plant and Quadrise should receive $1.5m in payments by June 2026. The share price declined 10.5% to 2.685p.

Aferian (LON: AFRN) has extended the repayment deadline for its bank facilities of $16.5m to 12 December as it explores the potential sales of the Amino and 24i business and the company as a whole. The £1.125m loan from Kestrel matures at the end of January 2026. The video streaming technology provider will publish a trading statement in December. The share price slipped 7.5% to 1.85p.

essensys (LON: ESYS) founder and non-executive director Mark Furness, who stepped down as chief executive in May, has submitted an indicative offer of 20p/share for the developer of Software-as-a-Service and cloud services for the flexible workspace sector. In April 2022, Mark Furness bought 20,934 shares at 94.5p each, taking his stake to 30.4%. This offer would value essensys at £13m. A trading statement revealed revenues of £4.1m in the quarter to October 2025, but a contract worth £900,000 each year is set to end in December. There will be cost savings, but 2025-26 results will be lower than expected. A debt facility is being negotiated. The figures for the year to July 2025 have not been published, but a previous trading statement indicated a fall in revenues from £24.1m to £19.2m with cash of £1.8m. The share price initially rose, but it is currently 6.45% lower at 14.5p. essensys joined AIM on 29 May 2019 when it raised £14m at 151p/share.  

Mitchells & Butlers shares jump as recent trading picks up

Mitchells & Butlers shares rose on Friday after announcing strong full-year results with like-for-like sales up 4.3%, outperforming the market by around 3%.

The company reported adjusted operating profit of £330m, up 5.8% on the prior year, with margins improving to 12.2%.

Total revenue reached £2,711m for the 52 weeks ended 27 September 2025.

Trading was particularly robust during the festive period last year, with like-for-like sales surging 10.4%. Investors will hope this can be replicated in the coming weeks.

The first quarter achieved 3.9% growth despite adverse weather, whilst the second quarter delivered 4.7% growth aided by good weather and strong Mother’s Day trading.

Third-quarter performance benefited from Easter’s timing shift, achieving 5% like-for-like growth. The fourth quarter saw 3.2% growth, with solid performances in mid-market pubs and restaurants, though London and premium venues were slightly weaker.

But investors will be more interested in what’s happened since the end of the period and a pick up in trade at the beginning of their new financial year.

Mitchells & Butlers shares were 8% higher at the time of writing.

“Mitchells & Butlers is one of the first consumer-facing companies to assess the impact of tax rises and the further hike in the National Living Wage. In its full-year results, like-for-like sales growth was a smidgen ahead of recent guidance, up 4.3%, with total revenue coming in at £2.7 billion,” said Derren Nathan, head of equity research, Hargreaves Lansdown.

“Operating profit rose £22 million to £322 million. After a slowdown in fourth quarter trading, markets should respond well today to news of a bounce back in the last 8 weeks, with resilient like-for-like growth of 3.8%. Cost inflation guidance for this year was already high at 6% so there may be some relief that this remains unchanged in the wake of recent policy announcements with the shares up 8% at the open.”

European Metals shares soar after €360m grant award for Czech lithium project

European Metals Holdings shares surged on Friday after announcing that its subsidiary Geomet has been awarded a grant of up to €360m for the development of the Cinovec Lithium Project in the Czech Republic, subject to completion of administrative processes.

The funding comes through the “Strategic Investments for a Climate-Neutral Economy” programme, administered by the Czech Ministry of Industry and Trade, and recognises the importance of the asset for future security of European lithium supply.

The European Commission designated it a Strategic Project under the EU Critical Raw Materials Act, whilst the Czech Government classified it as a Strategic Deposit.

European Metals Holdings shares shot up by around 70% before easing back.

Investors will be delighted to see the deal done with lithium plays attracting nowhere near as much interest as they once did.

“This is a transformational milestone for European Metals and the Cinovec Project,” said Executive Chairman, Keith Coughlan.

“The Czech Government’s award of a grant of up to EUR 360 million represents one of the largest direct project-level funding commitments to a critical raw materials project within the European Union. Following the previously detailed formal recognition of the Project, the approval of such a significant financial contribution clearly demonstrates the support for and importance of Cinovec in the future of European electromobility.

“Coming at a time of renewed positive outlook for lithium and strong geopolitical commitment to Critical Raw Material supply chain security, the grant confirms the significant support at both Czech Government and European Union levels.”

The grant, which will be paid in Czech koruna as a reimbursement of eligible capital expenditure, represents up to 35% of qualifying project costs for investments in designated Czech cohesion regions.

The project has also secured a $36 million grant from the EU Just Transition Fund.

The final grant amount will be confirmed upon formal award and may be less than the maximum €360 million allocation.

Serabi reports record Q3 production as profit doubles

Serabi Gold has delivered shareholders a bumper period of performance in the first nine months of 2025, with production rising 19% and profitability nearly doubling compared with the prior year period.

The Brazil-focused gold miner produced 32,634 ounces in the nine months to 30 September, up from 27,499 ounces in the same period last year.

Third-quarter production reached a record 12,090 ounces, positioning the company to meet its full-year guidance.

Higher gold prices and increased production saw EBITDA surge 95% to $48.2 million from $24.7 million, whilst post-tax profit climbed 96% to $34.9 million. Earnings per share nearly doubled to 46.10 cents from 23.55 cents.

The company’s balance sheet strengthened considerably, with cash holdings exploding to $38.8 million at quarter-end from $22.2 million at year-end 2024.

Operating cash inflow reached $34.3 million for the nine-month period, after mine development expenditure of $4.1 million, compared with $18.2 million in the prior year period.

Cash costs edged up marginally to $1,429 per ounce from $1,405 per ounce, whilst all-in sustaining costs rose to $1,816 per ounce from $1,790 per ounce. With the gold price above $4,000, Serabi is enjoying a healthy margin.

“The continued strong operational performance combined with higher average gold prices has driven a 95% year-on-year increase in EBITDA to $48.2 million and the Company closed the quarter with a cash balance of $38.8 million, up from $22.2 million at 31 December 2024,” said Colm Howlin, CFO.

“Net cash inflow from operations for the nine-month period, after mine development expenditure of $4.1 million, was $34.3 million, highlighting the strong cash-generating capacity of the business.

“All-In Sustaining Cost (AISC) averaged $1,816 per ounce for the period, reflecting the impact of ongoing development investment and inflationary cost pressures. We continue to strengthen our balance sheet with margins remaining robust, supported by firm gold prices, higher production volumes, and disciplined cost control.

“In parallel, exploration and resource development drilling continued across both the Palito Complex and Coringa, with approximately 27,937 metres completed year to date. Early results are encouraging, supporting the Company’s objective of increasing resources to the 1.5-2.0Moz range in the oncoming years as part of Phase 2 of our growth strategy.”

Critical metals and AI infrastructure with Majestic Corporation

The UK Investor Magazine was delighted to welcome Krystal Lai, Head of Communications at Majestic Corporation, back to the Podcast for another insightful discussion around critical minerals and urban mining.

This time, we focus on critical metals and AI infrastructure.

This episode explores AI infrastructure’s material demands and the data centre waste recycling opportunity.

We look beyond AI’s power consumption to the physical metals driving the technology and their end-of-life value.

The conversation examines specific metals in GPUs and AI hardware, assessing how infrastructure buildout affects global metal demand and how recycling is a key element to securing future supply.

Krystal details which AI infrastructure metals urban miner Majestic recovers, their current exposure to data centre waste, and the projected growth in this segment.

We finish by looking at how Majestic is positioning to capture the opportunity.

UK Small Caps: A reality check

Abby Glennie and Amanda Yeaman, Co-Managers of Aberdeen UK Smaller Companies Growth Trust, explore why UK small caps remain undervalued and highlight the long-term growth opportunities they see in the sector.

Investors have had plenty of reasons to be pessimistic about the UK economy, but the pervasive gloom may leave them overlooking a potential source of growth and diversification in their portfolios. For UK small and mid cap stocks, sentiment remains significantly out of step with reality and fears over the UK’s domestic growth may be clouding investors’ judgment.

The UK’s larger companies have soared since the start of 2025, outpacing even a resurgent S&P 500 . However, the small and mid cap segments have been left in their wake. While the absolute returns have been reasonable, and there have been individual success stories, they remain out of step with the operational performance of companies in this part of the market.

We recognise the challenges for the UK economy. However, the high quality UK small and mid cap companies do not need a strong economy to thrive: the economy is not the stock market. In abrdn UK Smaller Companies Growth Trust, 44% of revenues come from outside the UK, and those drawn from inside the UK come from sectors such as infrastructure, defence or technology, where GDP growth is not the driving force for their profitability.

In spite of the numerous fiscal pressures, and the speculation over tax rises in the budget, these companies have continued to perform well. Overall, UK small companies are forecast to grow their earnings at over 10% for 2025 and many of the companies in our portfolio have delivered even stronger results, including Cranswick, Morgan Sindall and Chemring.

This is not an historical anomaly. Over the long term, smaller companies have delivered earnings growth ahead of the UK market, while the FTSE 250 has delivered an annualised return of 13% over the last 20 years. Earnings growth for all UK markets – FTSE 100, 250 and small cap – is now forecast to be stronger than that of the US. The UK is home to many dynamic, innovative companies that are global leaders in their field. The UK offers compelling opportunities, within infrastructure, within defence, within AI.

The sentiment problem

The problem is sentiment – and more specifically, sentiment among UK investors, who have historically been the natural buyers of UK small and mid cap equities. While UK investors have been on hold, international investors have been steadily increasing their exposure as they recognise the attractiveness of valuations in the UK market and the earnings potential of individual companies.

We see these international buyers joining the share registers. Many appear to be looking to diversify away from US large cap technology where valuations are – on almost any measure – extremely stretched. We also see this international interest manifest in merger and acquisition activity. One-fifth of the FTSE 250 has been acquired since the start of the year. That shows the strategic value that external buyers are seeing in the UK market.

The price an investor pays for the growth they receive is an important determinant of their long-term return. UK small caps are trading on historically low valuations. They are low versus their own history and low versus other markets. These companies are not cheap because of weaker fundamentals, but because they have been neglected.

What could change?

Low valuation is clearly not enough by itself to shift sentiment in the UK market. There have been more than 50 months of outflows seen from UK equities and pessimism is entrenched. Factors that should have improved investor confidence in smaller companies – such as lower interest rates – have failed to make an impact. The same is true for inflation, which now appears to have peaked, but has not yet improved sentiment.

Nevertheless, we are starting to sense a change in mood since the start of the year. Investors are starting to worry about their US large cap exposure. They recognise that their global exposure is, in reality, a significant bet on US technology. They may not want to exit, but they want to control it by allocating elsewhere.

There have been dominant exposures in markets before – Japan, technology, emerging markets – but none of them have continued forever. The AI trend is currently 15 years old. There is more commentary around diversification and bubbles and a real nervousness across the market.

UK small and mid caps offer strong diversification benefits, at bargain basement valuations –FTSE 250 companies trade on half the valuation of those in the S&P 500, yet have the same estimated shareholder returns. Investors are looking for this type of investment profile to reduce volatility and enhance long-term performance. A lot of money has been made in the US, but given the starting valuations, there is an argument that the next decade may look different.

The case for small caps

With valuations deeply discounted and investors across the globe looking to rotate away from US mega-caps, investors have a rare opportunity to buy into an asset class with proven growth characteristics while sentiment is still weak.

On the abrdn UK Smaller Companies Growth Trust, we have companies such as Rotork, which makes flow control and actuators, or vending machine business ME Group that is growing aggressively through acquisition. We hold Morgan Sindall, which is taking full advantage of a strong backdrop for UK infrastructure, while Chemring and Avon Technologies are benefitting from increased defence spending.

UK Smaller companies present a rare opportunity: they offer a combination of good earnings growth, low valuations and diversification potential, at a time when investors are receptive to new ideas. Investors should not let short-term pessimism over the UK economy obscure the real value inherent in the UK’s unsung heroes.

Important information

Risk factors you should consider prior to investing: 

  • The value of investments and the income from them can fall and investors may get back less than the amount invested.
  • Past performance is not a guide to future results.
  • Company/Companies selected for illustrative purposes only to demonstrate the investment management style described herein and not as an investment recommendation or indication of future performance

Other important information:

The details contained here are for information purposes only and should not be considered as an offer, investment recommendation, or solicitation to deal in any investments or funds and does not constitute investment research, investment recommendation or investment advice in any jurisdiction. Any data contained herein which is attributed to a third party (“Third Party Data”) is the property of (a) third party supplier(s) (the “Owner”) and is licensed for use with Aberdeen. Third Party Data may not be copied or distributed. Third Party Data is provided “as is” and is not warranted to be accurate, complete or timely. To the extent permitted by applicable law, none of the Owner, Aberdeen, or any other third party (including any third party involved in providing and/or compiling Third Party Data) shall have any liability for Third Party Data or for any use made of Third Party Data. Neither the Owner nor any other third party sponsors, endorses or promotes the fund or product to which Third Party Data relates.

FTSE International Limited (“FTSE”) © FTSE 2025 “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All Rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for the errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Issued by abrdn Fund Managers Limited, registered in England and Wales (740118) at 280 Bishopsgate, London EC2M 4AG, authorised and regulated by the Financial Conduct Authority in the UK.

The abrdn UK Smaller Companies Growth Trust Key Information Document can be obtained here.

Find out more at https://www.aberdeeninvestments.com/en-gb/ausc or by registering for updates. You can also follow us on XFacebookYouTube and LinkedIn. 

AIM movers: boohoo optimistic and ex-dividends

2

Online retailer Boohoo (LON: DEBS) is starting to turnaround its business and management believe it could be earning BITDA of £50m in three years. In the six months to August 2025, revenues fell from £385.4m to £296.9m, but there was a swing from an adjusted loss of £9.2m to an operating profit of £1.8m. There was still a pre-tax loss. Cost savings have been made and a full year pre-tax loss of £11.5m is forecast. Nt debt should start to decline. There is a new incentive scheme for executives. The share price rebounded 38.8% to 16.1p.

Team (LON: TEAM) has launched a recommended bid for WH Ireland (LON: WHI). It is offering 0.195 of a share for each WH Ireland share and the WH Ireland shareholders will own 43.5% of the enlarged group, which will be valued at around £30m. The WH Ireland share price is one-quarter higher at 3.75p, while the Team share price rose 1.82% to 28p.

Shares in Anglo Asian Mining (LON: AAZ) have returned from suspension 16.9% higher at 225p. Trading in the shares was suspended on Wednesday morning. ACG Metals is considering making an offer for the gold and copper producer, which has a resource base of more than 400,000 ounces of gold and one million tonnes of copper. The Xarxar and Garadag projects are still to be brought into production.

Energy efficiency services provider Earnz (LON: EARN) says that there will be no impact on its business from the Budget. The company is not reliant on the Energy Company Obligation, which was due to close in March anyway. The share price bounced back 7.79% to 4.15p.

Battery technology developer Gelion (LON: GELN) has made strong progress over the past year and recently strengthened its balance sheet through a £10.5m fundraising that should give it enough cash for two years. In the year to June 2025, revenues increased 36% to £2.7m, with one-third coming from the first commercial sales. That helped the operating loss fall by one-quarter to £6m. Gelion is making strong progress with partners, including TDK Corporation, with whom it expects to produce a commercial pouch cells prototype within the next 12 months. The Li-S technology is achieving strong results in relation to battery life and power performance. The share price recovered 5.19% to 20.25p.

FALLERS

Premier African Minerals (LON: PREM) has raised £500,000 at 0.0575p/share. This will be invested in the processing plant for the Zulu lithium and tantalum project. The share price dipped 16.7% to 0.0625p.

North Sea oil and gas company Jersey Oil & Gas (LON: JOG) says that the UK government proposals for replacing the energy profits levy with the oil and gas price mechanism (OGPM) provide clarity for the longer-term tax regime. The OGPM will come into force on 1 April 2030 or earlier if oil passes $74/barrel and gas goes above 57p/therm. There will be a 35% tax on revenues above those levels. Threshold prices for the tax will be set twice each year. Jersey Oil & Gas will assess the impact on the Buchan project. The share price fell 5.24% to 108.5p.

Production has recovered at Serica Energy (LON: SQZ). In November, it averaged more than 50,000 boepd and the acquisition of Prax Upstream – due to be completed in December – will add more. This prior to the planned outage at Triton. There are organic growth options now that the tax regime has been clarified. Third quarter revenues were $134m. Cash was $41m. The share price declined 4.88% to 171.4p.

Ex-dividends

Calnex Solutions (LON: CLX) is paying an interim dividend of 0.31p/share and the share price is unchanged at 49.5p.

CML Microsystems (LON: CML) is paying an interim dividend of 5p/share and the share price is unchanged at 302p.

Craneware (LON: CRW) is paying a final dividend of 18.5p/share and the share price declined 5p to 2135p.

Focusrite (LON: TUNE) is paying a dividend of 2.1p/share and the share price improved 7.5p to 205p.  

Michelmersh Brick (LON: MBH) is paying an interim dividend of 1.6p/share and the share price fell 0.2p to 86p.

MHA (LON: MHA) is paying a maiden dividend of 1p/share and the share price rose 0.5p to 169p.

Tatton Asset Management (LON: TAM) is paying an interim dividend of 12p/share and the share price dipped 2p to 696p.

Tristel (LON: TSTL) is paying a final dividend of 8.52p/share and the share price is 5p lower at 355p.

Volex (LON: VLX) is paying an interim dividend of 1.6p/share and the share price decreased 0.5p to 389.5p.

YouGov (LON: YOU) is paying a final dividend of 9.25p/share and the share price slid 11.5p to 255.5p.

FTSE 100 steady as Budget digested

The FTSE 100 was fairly steady on Thursday as investors continued to digest the economic implications of Rachel Reeves’ Autumn Budget.

With the US closed for Thanksgiving, there were few other catalysts for stocks on Thursday, and the FTSE 100 index retreated by 0.2% after a strong run yesterday afternoon.

“It’s the morning after the day before – voters, back-benchers and markets are all digesting Chancellor Rachel Reeve’s 2025 Autumn Budget,” said Emma Wall, Chief Investment Strategist, Hargreaves Lansdown.

“The back-benchers will hopefully be happy – the manifesto pledge not to explicitly change the rate of the big three taxes was not broken and the long contentious two child benefit cap lifted. The voters reaction will be clear come the local elections in May.

“The markets reacted reasonably well to all this. After an initial rapid fluctuation in bond yields, following the leaked OBR report ahead of the Chancellor’s speech, gilt yields trended flat – and down from last week, indicating the bond market at least thinks this is a fiscally responsible Budget. This will be a very welcome sign for the Chancellor.”

Beyond yesterday’s rally following the budget, there were encouraging signs for UK-centric stocks on Thursday.

Housebuilders Persimmon and Berkeley Group were between 0.8%-1.7% higher on Thursday, suggesting a vote of confidence from the market on the housing outlook.

Rightmove was also marginally higher.

UK-focused retailers were also among the gainers. The balance of measures implemented yesterday doesn’t seem to have worsened the consumer’s short-term propensity to spend, boosting interest in Sainsbury’s and Marks & Spencer.

UK banks NatWest and Lloyds also rose as the budget uncertainty cleared.

Investment manager rose amid hope that savers hit by the slashing of the Cash ISA allowance would take up investing products. Schroders rose 1.2% and St James’s Place was the FTSE 100’s top riser with a 2.5% gain.

Miners dragged on the index with Anglo American and Rio Tinto losing around 1%.

Imperial Brands, down 2.9%, was the top faller as it traded ex-dividend.